Skip to main content
Home

Medicines for Malaria Venture

Developing antimalarials to save lives

Main navigation

  • Our work
    • Go back
    • Our work
    • MMV's pipeline of antimalarial drugs
    • Global health and societal change
      • Go back
      • Global health and societal change
      • Sustainable Development Goals
      • Gender equity
      • Antimicrobial resistance
      • Antimalarial drugs for children
      • African manufacturing
    • Research and development
      • Go back
      • Research and development
      • Target Product & Candidate Profiles
      • Frontrunner templates
    • Access to medicines
  • Partnering & opportunities
    • Go back
    • Partnering & opportunities
    • Partner network
    • Business model
    • Intellectual property rights
    • Opportunities
      • Go back
      • Opportunities
      • Careers
      • Requests for information or proposals
      • Drug discovery call for proposals
  • Newsroom
  • Malaria
    • Go back
    • Malaria
    • Definitions and symptoms
    • Malaria facts and statistics
    • Lifecycle of malaria parasite
    • 5 species of Plasmodium parasites
    • History of antimalarial drugs
    • Malaria guidelines
  • About us
    • Go back
    • About us
    • About us
      • Go back
      • About us
      • FAQs
      • Diversity, Equity & Inclusion
      • Policies
      • Funding & expenditure
      • Donors
    • People & governance
      • Go back
      • People & governance
      • Staff bios
      • Board of Directors
      • North America Inc. Board
      • Access and Product Management Advisory Committee
      • Expert Scientific Advisory Committee
      • Global Safety Board
  • MMVOpen
    • Go back
    • MMVOpen
    • Open compound collections
      • Go back
      • Open compound collections
      • Global health priority box
      • Pandemic Response Box
    • Open dose and PK prediction tool
    • Open source drug discovery programme
    • MMVOpen team
What are you looking for?
Home MMV Open

MMV Open

MMV Open

MMVOpen

MMVOpen is taking open drug discovery to the next level. We are proud to host the initiatives below. 

Global Health Priority Box

A diverse collection of 240 compounds with activity against infective and neglected diseases, and vectors.

Pandemic Response Box

400 diverse drug-like molecules active against bacteria, viruses or fungi; available free of charge. 

MMVSola

An open tool for early antimalarial dose prediction and pharmacokinetic prediction in malaria and other diseases. 

Malaria Libre

An open source drug discovery programme aiming to deliver preclinical candidates for malaria treatment and prevention. 

Contact us

+41 22 555 03 00

info@mmv.org

Find us

Follow us

Facebook Linkedin Twitter YouTube

Subscribe

Previous newsletters
  • Disclaimer
  • Privacy policy
© MMV 2023
A site by Manta Ray Media